Kimberly Leuthner

407 total citations
15 papers, 322 citations indexed

About

Kimberly Leuthner is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Kimberly Leuthner has authored 15 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Pharmacology and 4 papers in Clinical Biochemistry. Recurrent topics in Kimberly Leuthner's work include Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Kimberly Leuthner is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Kimberly Leuthner collaborates with scholars based in United States. Kimberly Leuthner's co-authors include Gary V. Doern, Michael J. Rybak, Steve P. Lee, Chrissy M. Cheung, Céline Vidaillac, Judy N. Chin, Kerry L. LaPlante, Luis Felipe Reyes, Thomas P. Lodise and Winter J. Smith and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Kimberly Leuthner

14 papers receiving 309 citations

Peers

Kimberly Leuthner
Abi Jenkins United Kingdom
Bharath Sunkara United States
Joseph J. Carreno United States
Laura Whitney United Kingdom
R. Brigg Turner United States
Cássia Maria Zoccoli Brazil
Luis Bavestrello Chile
M. Layne Lillie United Kingdom
Marina Macedo-Viñas Switzerland
Ruchir Chavada Australia
Abi Jenkins United Kingdom
Kimberly Leuthner
Citations per year, relative to Kimberly Leuthner Kimberly Leuthner (= 1×) peers Abi Jenkins

Countries citing papers authored by Kimberly Leuthner

Since Specialization
Citations

This map shows the geographic impact of Kimberly Leuthner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Leuthner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Leuthner more than expected).

Fields of papers citing papers by Kimberly Leuthner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Leuthner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Leuthner. The network helps show where Kimberly Leuthner may publish in the future.

Co-authorship network of co-authors of Kimberly Leuthner

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Leuthner. A scholar is included among the top collaborators of Kimberly Leuthner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Leuthner. Kimberly Leuthner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sabour, Andrew, et al.. (2022). Invasive cutaneous mucormycosis: A case report on a deadly complication of a severe burn. IDCases. 30. e01613–e01613. 3 indexed citations
2.
Chen, Catherine, et al.. (2020). Safety of Prolonged Dexmedetomidine Use in Pediatric Patients. 4(1). 1–6. 1 indexed citations
3.
4.
Sierra‐Hoffman, Miguel, et al.. (2018). 569: MINOCYCLINE IV IS EFFECTIVE IN THE TREATMENT OF INFECTIONS DUE TO GRAM-NEGATIVE BACTERIA. Critical Care Medicine. 47(1). 265–265.
5.
Leuthner, Kimberly, et al.. (2017). Real-world Evaluation of Ceftolozane/Tazobactam (C/T) Use and Clinical Outcomes at an Academic Medical Center in Las Vegas. Open Forum Infectious Diseases. 4(suppl_1). S296–S297. 5 indexed citations
6.
Leuthner, Kimberly, et al.. (2016). Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Therapeutics and Clinical Risk Management. 12. 931–931. 35 indexed citations
7.
Leuthner, Kimberly, et al.. (2016). Drug-Induced Hemolytic Anemia From Ceftazidime/Avibactam, A New Old Antimicrobial: A Case Report.. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
8.
Leuthner, Kimberly, et al.. (2015). Dalbavancin (BI-387) for the treatment of complicated skin and skin structure infection. Expert Review of Anti-infective Therapy. 13(2). 149–159. 7 indexed citations
9.
Moise, Pamela, Annie Wong‐Beringer, Kenneth C. Lamp, et al.. (2015). Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Clinical Therapeutics. 38(1). 16–30. 50 indexed citations
10.
Leuthner, Kimberly & Gary V. Doern. (2013). Antimicrobial Stewardship Programs. Journal of Clinical Microbiology. 51(12). 3916–3920. 58 indexed citations
11.
Leuthner, Kimberly, et al.. (2013). Antimicrobial Stewardship and Clostridium difficile–Associated Diarrhea. Journal of Pharmacy Practice. 26(5). 506–513. 14 indexed citations
12.
Leuthner, Kimberly, Céline Vidaillac, Chrissy M. Cheung, & Michael J. Rybak. (2010). In Vitro Activity of the New Multivalent Glycopeptide-Cephalosporin Antibiotic TD-1792 against Vancomycin-Nonsusceptible Staphylococcus Isolates. Antimicrobial Agents and Chemotherapy. 54(9). 3799–3803. 21 indexed citations
13.
14.
LaPlante, Kerry L., Michael J. Rybak, Kimberly Leuthner, & Judy N. Chin. (2006). Impact of Enterococcus faecalis on the Bactericidal Activities of Arbekacin, Daptomycin, Linezolid, and Tigecycline against Methicillin-Resistant Staphylococcus aureus in a Mixed-Pathogen Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 50(4). 1298–1303. 17 indexed citations
15.
Leuthner, Kimberly, Chrissy M. Cheung, & Michael J. Rybak. (2006). Pulsatile Delivery of Clarithromycin Alone or in Combination with Amoxicillin against Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 50(2). 813–816. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abi Jenkins Breakdown of academic impact, for papers by Bharath Sunkara Breakdown of academic impact, for papers by Joseph J. Carreno Breakdown of academic impact, for papers by Laura Whitney Breakdown of academic impact, for papers by R. Brigg Turner Breakdown of academic impact, for papers by Cássia Maria Zoccoli Breakdown of academic impact, for papers by Luis Bavestrello Breakdown of academic impact, for papers by M. Layne Lillie Breakdown of academic impact, for papers by Marina Macedo-Viñas Breakdown of academic impact, for papers by Ruchir Chavada
Rankless by CCL
2026